Skip to content

Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery

Prospective Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05860790
Enrollment
1000
Registered
2023-05-16
Start date
2023-03-10
Completion date
2023-07-01
Last updated
2023-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurosurgery, Risk Assessment, Venous Thromboembolism

Brief summary

Validation of Clinical Prediction Model for Venous Thromboembolism Following Neurosurgery: A Multicenter, Prospective, and Cohort Study

Detailed description

A clinical prediction model for VTE after neurosurgical procedures during hospitalization has been developed and internally retrospectively validated. A multicenter, prospective cohort study is planned to validate this clinical prediction model again.

Interventions

DIAGNOSTIC_TESTClinical Prediction Model for Venous Thromboembolism Following Neurosurgery

This is a clinical prediction model that uses perioperative clinical indicators and laboratory tests to predict the occurrence of VTE after neurosurgery.

Sponsors

Capital Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. age \>18 years 2. underwent neurosurgical procedures during hospitalization 3. underwent preoperative ultrasound examination

Exclusion criteria

1. a patient with obvious bacterial or viral infection within the past two weeks before admission 2. a patient with venous thromboembolism within the past three months before surgery 3. a patient with anticoagulant therapy (direct oral anticoagulants, low molecular weight heparin) was administered continuously or intermittently before admission 4. a patient with a prior coagulation dysfunction

Design outcomes

Primary

MeasureTime frameDescription
Symptomatic or asymptomatic VTE2023.3-2023.7A combination of symptomatic or asymptomatic DVT and symptomatic or asymptomatic PE

Secondary

MeasureTime frameDescription
DVT2023.3-2023.7A blood clot within a deep vein, typically in the thigh or leg, which is detected with compressible ultrasound, venography, impedence plethysmography, radiofibrinogen uptake scanning or autopsy based on the time of study. This outcome combines proximal or distal DVT of the leg, upper limb DVT
PE2023.3-2023.7Obstruction of a pulmonary artery or one of its branches that is usually produced by a blood clot which has originated in a vein of the leg or pelvis and traveled to the lungs, which is diagnosed by CT pulmonary angiography, ventilation-perfusion lung scanning pulmonary angiogram, or by autopsy or equivalent technology based on the time of study. This outcome combines saddle, lobar, segmental or subsegmental PE according to the anatomic location
Proximal DVT2023.3-2023.7Proximal DVT is a blood clot that is located in the popliteal, femoral, or iliac veins, which is detected with compressible ultrasound, venography, impedence plethysmography, radiofibrinogen uptake scanning or autopsy based on the time of study

Countries

China

Contacts

Primary ContactDeshan Liu, Dr.
alfredliu@mail.ccmu.edu.cn15613318871

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026